期刊文献+

乙型肝炎病毒蛋白和绿色荧光蛋白的共表达研究 被引量:5

Co-Expression of Hepatitis B Virus Proteins and Green Fluorescent Protein After Eukaryotic Cell in vitro and Hydrodynamics-Based in vivo Transfection
下载PDF
导出
摘要 目的:构建增强型绿色荧光蛋白(EGFP)标记的乙型肝炎病毒(HBV)真核表达载体,并研究其在真核细胞和小鼠体内的共表达。方法:以质粒pBR322-HBVadr2.0和pCX-EGFP为基础,构建含有双拷贝HBV全基因组DNA和EGFP基因的真核表达载体pCX-EGFP-HBVadr2.0,分别转染真核细胞和小鼠肝组织,建立体外、体内表达系统,研究GFP和HBV基因的表达。结果:构建了真核表达载体pCX-EGFP-HBVadr2.0,EGFP和HBV病毒蛋白在体内和体外均可表达。结论:构建的pCX-EGFP-HBVadr2.0真核表达载体可以GFP作为HBV存在与否的报告基因,提高了培育检测转基因小鼠的效率,为转基因小鼠的制备及后续研究奠定了基础。 Objective: To construct pCX-EGFP-HBVadr2.0 eukaryotic expression vector harboring 2 copies of hepatitis B virus(HBV) genomic DNA and enhanced green fluorescent protein(EGFP) gene and investgate the co-expression in vitro and in vivo. Methods: The eukaryotic expression vector pCX-EGFP-HBVadr2.0 was constructed based on plasmids of pBR322-HBVadr2.0 harboring 2 copies of HBV genomic DNA and vector pCX-EGFP containing CMV-IE enhancer, chicken B-action promoter and EGFP by recombination DNA technique. The HBV genomic DNA and EGFP gene expressing in transfected L02 cell line in vitro and hydrodynamic injected mouse in vivo were studied. Results: The eukaryotic expression vector pCX-EGFP-HBVadr2.0 was constructed, and could expressed in vitro and in vivo. Conclusion: The HBV eukaryotic expression vector carrying EGFP reporter gene to generate transgenic mice was constructed. It should be practicable and effective in breeding and estimation by using HBV transgenic mice with the EGFP.
出处 《生物技术通讯》 CAS 2008年第2期167-170,共4页 Letters in Biotechnology
关键词 乙型肝炎病毒 增强型绿色荧光蛋白 真核表达载体 转基因小鼠 hepatitis B virus enhanced green fluorescent protein transgenic mice eukaryotic expression vector
  • 相关文献

参考文献2

二级参考文献28

  • 1Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH,Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000;15:1356-1361. 被引量:1
  • 2Birrer RB, Birrer D, Klavins JV. Hepatocellular carcinoma and hepatitis virus. Ann Clin Lab Sci 2003; 33:39-54. 被引量:1
  • 3Rabe C, Cheng B, Caselmann WH. Molecular mechanisms of hepatitis B virus-associated liver cancer. Dig Dis 2001; 19:279-287. 被引量:1
  • 4vArbuthnot P, Kew M. Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol 2001; 82:77-100. 被引量:1
  • 5Brechot C, Gozuacik D, Murakami Y, Paterlini-Brechot P. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin Cancer Biol 2000;10:211-231. 被引量:1
  • 6Lee KM, Kim YS, Ko YY, Yoo BM, Lee KJ, Kim JH, Hahm KB,Cho SW. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci 2001; 16:359-362. 被引量:1
  • 7Kidd-Ljunggren K, Miyakawa Y, Kidd AH. Genetic variability in hepatitis B viruses. J Gen Virol 2002; 83(Pt 6): 1267-1280. 被引量:1
  • 8Hu YP, Hu WJ, Zheng WC, Li JX, Dai DS, Wang XM, Zhang SZ,Yu HY, Sun W, Hao GR. Establishment of transgenic mouse harboring hepatitis B virus (adr subtype) genomes. World J Gastroenterol 2001; 7:111-114. 被引量:1
  • 9$ingh M, Kumar V. Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma. Rev Med Virol 2003;13:243-253. 被引量:1
  • 10Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV.Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol 2002; 169:5188-5195. 被引量:1

共引文献9

同被引文献58

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部